Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Mills

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The International Journal on Drug Policy|May 18, 2010
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infectionScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 22, 2008
The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meetingStephen Barclay, Stanislas Pol, David Mutimer, et al.
Aging Cell|August 13, 2013
Non cell autonomous upregulation of CDKN2 transcription linked to progression of chronic hepatitis C diseaseMark W Robinson, Dagmara McGuinness, Rachael Swann, et al.
European Journal of Gastroenterology & Hepatology|February 17, 2012
Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosisSudeep Tanwar, Mark Wright, Graham R Foster, et al.
Gastroenterology|July 18, 2013
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseasePaul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, et al.
Microbiology (Reading, England)|January 30, 2010
The pmk1-like mitogen-activated protein kinase from Lecanicillium (Verticillium) fungicola is not required for virulence on Agaricus bisporusPatrick D Collopy, Richard C Amey, Martin J Sergeant, et al.
European Journal of Gastroenterology & Hepatology|September 24, 2009
Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage studyScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
Journal of Hepatology|February 11, 2014
Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation modelHamish Innes, David Goldberg, Geoffrey Dusheiko, et al.
European Journal of Gastroenterology & Hepatology|April 12, 2008
The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testingStuart Watkins, Douglas Thorburn, Neeraj Joshi, et al.
Frontiers in Immunology|April 20, 2016
Tracking TCRβ Sequence Clonotype Expansions during Antiviral Therapy Using High-Throughput Sequencing of the Hypervariable RegionMark W Robinson, Joseph Hughes, Gavin S Wilkie, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The International Journal on Drug Policy|May 18, 2010
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infectionScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 22, 2008
The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meetingStephen Barclay, Stanislas Pol, David Mutimer, et al.
Aging Cell|August 13, 2013
Non cell autonomous upregulation of CDKN2 transcription linked to progression of chronic hepatitis C diseaseMark W Robinson, Dagmara McGuinness, Rachael Swann, et al.
European Journal of Gastroenterology & Hepatology|February 17, 2012
Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosisSudeep Tanwar, Mark Wright, Graham R Foster, et al.
Gastroenterology|July 18, 2013
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseasePaul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, et al.
Microbiology (Reading, England)|January 30, 2010
The pmk1-like mitogen-activated protein kinase from Lecanicillium (Verticillium) fungicola is not required for virulence on Agaricus bisporusPatrick D Collopy, Richard C Amey, Martin J Sergeant, et al.
European Journal of Gastroenterology & Hepatology|September 24, 2009
Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage studyScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
Journal of Hepatology|February 11, 2014
Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation modelHamish Innes, David Goldberg, Geoffrey Dusheiko, et al.
European Journal of Gastroenterology & Hepatology|April 12, 2008
The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testingStuart Watkins, Douglas Thorburn, Neeraj Joshi, et al.
Frontiers in Immunology|April 20, 2016
Tracking TCRβ Sequence Clonotype Expansions during Antiviral Therapy Using High-Throughput Sequencing of the Hypervariable RegionMark W Robinson, Joseph Hughes, Gavin S Wilkie, et al.
Pageof 6